{"id":499653,"date":"2021-05-28T07:08:07","date_gmt":"2021-05-28T11:08:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/"},"modified":"2021-05-28T07:08:07","modified_gmt":"2021-05-28T11:08:07","slug":"ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/","title":{"rendered":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021"},"content":{"rendered":"

\nOnline event to include a live reading by Children\u2019s Author, Ariana Feiner, whose short film documentary, A Story of Courage, has won 24 international awards
\n<\/h2>\n
\n

COPENHAGEN, Denmark, May 28, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A\/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon\u2122\u00a0technologies to create new product candidates that address unmet medical needs, today announced\u00a0an online event<\/a> with members of the hypoparathyroidism community to be held on Tuesday, June 1 in support of World Hypopara Awareness Day.<\/p>\n

The live, online event seeks to raise awareness of hypoparathyroidism worldwide and share Ariana Feiner\u2019s uplifting message of hope and inspiration to those affected by chronic illness.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n Who:<\/strong>\n <\/td>\n\n Ariana Feiner<\/a>, Children\u2019s Author, Filmmaker and Educator<\/td>\n<\/tr>\n
\u00a0<\/td>\nLiz Glenister, CEO and Founder,\u00a0Parathyroid UK<\/a><\/td>\n<\/tr>\n
\u00a0<\/td>\nBob Sanders, Chairman of the Board,\u00a0HypoPARAthyroidism Association, Inc.<\/a><\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n What:<\/strong>\n <\/td>\n\n A Story of Courage: Living with Hypoparathyroidism<\/a>\u00a0will include remarks by members of the community, followed by a live reading and discussion<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n When:<\/strong>\n <\/td>\nJune 1, 2021<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n12:00 p.m. Pacific Time (U.S.)<\/td>\n<\/tr>\n
\u00a0<\/td>\n3:00 p.m. Eastern Time (U.S.)<\/td>\n<\/tr>\n
\u00a0<\/td>\n8:00 p.m. British Summer Time (U.K.)<\/td>\n<\/tr>\n
\u00a0<\/td>\n9:00 p.m. Central European Time (Europe)<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Where:<\/strong>\n <\/td>\nVisit the event page at\u00a0www.astoryofcourage.live<\/a> for more information and to add to your calendar.<\/td>\n<\/tr>\n<\/table>\n

#WorldHypoparaDay
#Hypoparathyroidism
#AStoryofCourage<\/p>\n

\n About Hypoparathyroidism (HP)<\/strong>
\n 1<\/sup>
\n ,<\/sup>
\n 2<\/sup>
\n ,<\/sup>
\n 3<\/sup>
\n ,<\/sup>
\n 4<\/sup>
\n ,<\/sup>
\n 5<\/sup>
\n ,<\/sup>
\n 6<\/sup>\n <\/p>\n

Hypoparathyroidism (HP) is a rare endocrine disorder characterized by insufficient levels of parathyroid hormone (PTH), resulting in low calcium and elevated phosphate levels in the blood. HP affects approximately 200,000 patients in\u00a0the United States,\u00a0Europe,\u00a0Japan\u00a0and\u00a0South Korea, the majority of whom develop the condition following damage or accidental removal of the parathyroid glands during thyroid surgery. Patients often experience decreased quality of life. In the short term, symptoms include weakness, severe muscle cramps (tetany), abnormal sensations such as tingling, burning and numbness (paresthesia), memory loss, impaired judgment and headache. Over the long term, this complex disorder can increase risk of major complications, such as extraskeletal calcium depositions occurring within the brain, lens of the eye, and kidneys, which can lead to impaired renal function.<\/p>\n

\n About\u00a0Ascendis Pharma A\/S\u00a0<\/strong>\n <\/p>\n

Ascendis Pharma\u00a0is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients\u2019 lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon technologies to create new and potentially best-in-class therapies.<\/p>\n

Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product candidates and one oncology product candidate in clinical development. The company continues to expand into additional therapeutic areas to address unmet patient needs.<\/p>\n

Ascendis is headquartered in\u00a0Copenhagen, Denmark, with additional offices in Heidelberg and\u00a0Berlin, Germany, in\u00a0Palo Alto\u00a0and\u00a0Redwood City, California, and in Princeton, New Jersey.<\/p>\n

Please visit www.ascendispharma.com<\/a> (for global information) or www.ascendispharma.us<\/a> (for U.S. information).<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis\u2019 future operations, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, statements relating to (i) Ascendis\u2019 ability to apply its platform technology to build a leading, fully integrated biopharma company, (ii) Ascendis\u2019 product pipeline and expansion into additional therapeutic areas and (iii) Ascendis\u2019 expectations regarding its ability to utilize its TransCon technologies to create new and potentially best-in-class therapies. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including the following: unforeseen safety or efficacy results in its oncology programs, TransCon hGH, TransCon PTH and TransCon CNP or other development programs; unforeseen expenses related to the development and potential commercialization of its oncology programs, TransCon hGH, TransCon PTH and TransCon CNP or other development programs, selling, general and administrative expenses, other research and development expenses and Ascendis\u2019 business generally; delays in the development of its oncology programs, TransCon hGH, TransCon PTH and TransCon CNP or other development programs related to manufacturing, regulatory requirements, speed of patient recruitment or other unforeseen delays; dependence on third party manufacturers to supply study drug for planned clinical studies; Ascendis\u2019 ability to obtain additional funding, if needed, to support its business activities and the effects on its business from the worldwide COVID-19 pandemic. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis\u2019 business in general, see Ascendis\u2019 Annual Report on Form 20-F filed with the\u00a0U.S. Securities and Exchange Commission\u00a0(SEC) on\u00a0March 10, 2021\u00a0and Ascendis\u2019 other future reports filed with, or submitted to, the\u00a0SEC. Forward-looking statements do not reflect the potential impact of any future in-licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.<\/p>\n

\n Ascendis,\u00a0Ascendis Pharma, the\u00a0Ascendis Pharma\u00a0logo, the company logo and TransCon are trademarks owned by the\u00a0Ascendis Pharma Group. \u00a9\u00a0May 2021\u00a0Ascendis Pharma A\/S.<\/em>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n
\n Investor contacts:<\/u>
\n <\/strong>\n <\/td>\n		\n
\n Media contact:<\/u>
\n <\/strong>\n <\/td>\n<\/tr>\n
Tim Lee<\/td>\nAmi Knoefler<\/td>\n<\/tr>\n
Ascendis Pharma<\/td>\nAscendis Pharma<\/td>\n<\/tr>\n
(650) 374-6343<\/td>\n(650) 739-9952<\/td>\n<\/tr>\n
\n tle@ascendispharma.com<\/a>\n <\/td>\n\n ack@ascendispharma.com<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Patti Bank<\/td>\n\u00a0<\/td>\n<\/tr>\n
Westwicke Partners<\/td>\n\u00a0<\/td>\n<\/tr>\n
(415) 513-1284<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n patti.bank@westwicke.com<\/a>\n <\/td>\n\u00a0<\/td>\n<\/tr>\n
\n ir@ascendispharma.com<\/a>\n <\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n 1<\/sup> Mannstadt M, et al. Nature <\/em>Reviews<\/em>\u00a02017, 3: 17055
2<\/sup> Ascendis Pharma HP Patient Experience Research.
3<\/sup> Hadker N, et al. Endo Pract.<\/em> 2014, 20(7);671-679.
4<\/sup> Powers J, et al. J Bone Miner Res<\/em> 2013, 28: 2570-2576.
5<\/sup> Mitchell DM, et al. J Clin Endocrinol Metab<\/em> 2012, 97(12): 4507-4514
6<\/sup> Underbjerg L, et al. J Bone Miner Res<\/em> 2013, 28: 2277-2285<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Online event to include a live reading by Children\u2019s Author, Ariana Feiner, whose short film documentary, A Story of Courage, has won 24 international awards COPENHAGEN, Denmark, May 28, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A\/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon\u2122\u00a0technologies to create new product candidates that address unmet medical needs, today announced\u00a0an online event with members of the hypoparathyroidism community to be held on Tuesday, June 1 in support of World Hypopara Awareness Day. The live, online event seeks to raise awareness of hypoparathyroidism worldwide and share Ariana Feiner\u2019s uplifting message of hope and inspiration to those affected by chronic illness. Who: Ariana Feiner, Children\u2019s Author, Filmmaker and Educator \u00a0 Liz Glenister, CEO and … <\/p>\n

Continue reading “Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499653","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAscendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Online event to include a live reading by Children\u2019s Author, Ariana Feiner, whose short film documentary, A Story of Courage, has won 24 international awards COPENHAGEN, Denmark, May 28, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A\/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon\u2122\u00a0technologies to create new product candidates that address unmet medical needs, today announced\u00a0an online event with members of the hypoparathyroidism community to be held on Tuesday, June 1 in support of World Hypopara Awareness Day. The live, online event seeks to raise awareness of hypoparathyroidism worldwide and share Ariana Feiner\u2019s uplifting message of hope and inspiration to those affected by chronic illness. Who: Ariana Feiner, Children\u2019s Author, Filmmaker and Educator \u00a0 Liz Glenister, CEO and … Continue reading "Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-28T11:08:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ascendis Pharma A\\\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021\",\"datePublished\":\"2021-05-28T11:08:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/\"},\"wordCount\":997,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/\",\"name\":\"Ascendis Pharma A\\\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=\",\"datePublished\":\"2021-05-28T11:08:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ascendis Pharma A\\\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/","og_locale":"en_US","og_type":"article","og_title":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk","og_description":"Online event to include a live reading by Children\u2019s Author, Ariana Feiner, whose short film documentary, A Story of Courage, has won 24 international awards COPENHAGEN, Denmark, May 28, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A\/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon\u2122\u00a0technologies to create new product candidates that address unmet medical needs, today announced\u00a0an online event with members of the hypoparathyroidism community to be held on Tuesday, June 1 in support of World Hypopara Awareness Day. The live, online event seeks to raise awareness of hypoparathyroidism worldwide and share Ariana Feiner\u2019s uplifting message of hope and inspiration to those affected by chronic illness. Who: Ariana Feiner, Children\u2019s Author, Filmmaker and Educator \u00a0 Liz Glenister, CEO and … Continue reading \"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-28T11:08:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021","datePublished":"2021-05-28T11:08:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/"},"wordCount":997,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/","name":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=","datePublished":"2021-05-28T11:08:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTAwOSM0MjA2ODUxIzIwMTEyMzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascendis-pharma-a-s-invites-the-public-to-attend-a-story-of-courage-living-with-hypoparathyroidism-in-support-of-world-hypopara-awareness-day-on-june-1-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ascendis Pharma A\/S Invites the Public to Attend \u201cA Story of Courage: Living with Hypoparathyroidism\u201d in Support of World Hypopara Awareness Day on June 1, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499653"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499653\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}